Biblio

Export 1210 results:
Author Title [ Type(Asc)] Year
Filters: First Letter Of Last Name is R  [Clear All Filters]
Journal Article
R. Smith, Wibom, M., Olsson, T., Hägerström, D., Jögi, J., Rabinovici, G. D., and Hansson, O., “Posterior Accumulation of Tau and Concordant Hypometabolism in an Early-Onset Alzheimer's Disease Patient with Presenilin-1 Mutation.”, J Alzheimers Dis, vol. 51, no. 2, pp. 339-43, 2016.
M. Khondoker, Rafnsson, S. Bjorn, Morris, S., Orrell, M., and Steptoe, A., “Positive and Negative Experiences of Social Support and Risk of Dementia in Later Life: An Investigation Using the English Longitudinal Study of Ageing.”, J Alzheimers Dis, vol. 58, no. 1, pp. 99-108, 2017.
F. He, Luo, H., Yin, L., Roosaar, A., Axéll, T., Zhao, H., and Ye, W., “Poor Oral Health as a Risk Factor for Dementia in a Swedish Population: A Cohort Study with 40 Years of Follow-Up.”, J Alzheimers Dis, vol. 92, no. 1, pp. 171-181, 2023.
J. Lakey-Beitia, Burillo, A. M., La Penna, G., Hegde, M. L., and Rao, K. S., “Polyphenols as Potential Metal Chelation Compounds Against Alzheimer's Disease.”, J Alzheimers Dis, vol. 82, no. s1, pp. S335-S357, 2021.
V. K. Ramanan, Heckman, M. G., Przybelski, S. A., Lesnick, T. G., Lowe, V. J., Graff-Radford, J., Mielke, M., Jack, C. R., Knopman, D. S., Petersen, R. C., Ross, O. A., and Vemuri, P., “Polygenic Scores of Alzheimer's Disease Risk Genes Add Only Modestly to APOE in Explaining Variation in Amyloid PET Burden.”, J Alzheimers Dis, vol. 88, no. 4, pp. 1615-1625, 2022.
V. K. Ramanan, Heckman, M. G., Przybelski, S. A., Lesnick, T. G., Lowe, V. J., Graff-Radford, J., Mielke, M., Jack, C. R., Knopman, D. S., Petersen, R. C., Ross, O. A., and Vemuri, P., “Polygenic Scores of Alzheimer's Disease Risk Genes Add Only Modestly to APOE in Explaining Variation in Amyloid PET Burden.”, J Alzheimers Dis, vol. 88, no. 4, pp. 1615-1625, 2022.
M. E. Petersen, Rafii, M. S., Zhang, F., Hall, J., Julovich, D., Ances, B. M., Schupf, N., Krinsky-McHale, S. J., Mapstone, M., Silverman, W., Lott, I., Klunk, W., Head, E., Christian, B., Foroud, T., Lai, F., H Rosas, D., Zaman, S., Wang, M. - C., Tycko, B., Lee, J., Handen, B., Hartley, S., Fortea, J., and O'Bryant, S., “Plasma Total-Tau and Neurofilament Light Chain as Diagnostic Biomarkers of Alzheimer's Disease Dementia and Mild Cognitive Impairment in Adults with Down Syndrome.”, J Alzheimers Dis, vol. 79, no. 2, pp. 671-681, 2021.
M. E. Petersen, Rafii, M. S., Zhang, F., Hall, J., Julovich, D., Ances, B. M., Schupf, N., Krinsky-McHale, S. J., Mapstone, M., Silverman, W., Lott, I., Klunk, W., Head, E., Christian, B., Foroud, T., Lai, F., H Rosas, D., Zaman, S., Wang, M. - C., Tycko, B., Lee, J., Handen, B., Hartley, S., Fortea, J., and O'Bryant, S., “Plasma Total-Tau and Neurofilament Light Chain as Diagnostic Biomarkers of Alzheimer's Disease Dementia and Mild Cognitive Impairment in Adults with Down Syndrome.”, J Alzheimers Dis, vol. 79, no. 2, pp. 671-681, 2021.
K. D. Deters, Risacher, S. L., Kim, S., Nho, K., West, J. D., Blennow, K., Zetterberg, H., Shaw, L. M., Trojanowski, J. Q., Weiner, M. W., and Saykin, A. J., “Plasma Tau Association with Brain Atrophy in Mild Cognitive Impairment and Alzheimer's Disease.”, J Alzheimers Dis, vol. 58, no. 4, pp. 1245-1254, 2017.
M. Mapstone, Cheema, A. K., Fiandaca, M. S., Zhong, X., Mhyre, T. R., MacArthur, L. H., Hall, W. J., Fisher, S. G., Peterson, D. R., Haley, J. M., Nazar, M. D., Rich, S. A., Berlau, D. J., Peltz, C. B., Tan, M. T., Kawas, C. H., and Federoff, H. J., “Plasma phospholipids identify antecedent memory impairment in older adults.”, Nat Med, vol. 20, no. 4, pp. 415-8, 2014.
A. Pilotto, Imarisio, A., Carrarini, C., Russo, M., Masciocchi, S., Gipponi, S., Cottini, E., Aarsland, D., Zetterberg, H., Ashton, N. J., Hye, A., Bonanni, L., and Padovani, A., “Plasma Neurofilament Light Chain Predicts Cognitive Progression in Prodromal and Clinical Dementia with Lewy Bodies.”, J Alzheimers Dis, vol. 82, no. 3, pp. 913-919, 2021.
S. Pedrini, Hone, E., Gupta, V. B., James, I., Teimouri, E., Bush, A. I., Rowe, C. C., Villemagne, V. L., Ames, D., Masters, C. L., Rainey-Smith, S., Verdile, G., Sohrabi, H. R., Raida, M. R., Wenk, M. R., Taddei, K., Chatterjee, P., Martins, I., Laws, S. M., and Martins, R. N., “Plasma High Density Lipoprotein Small Subclass is Reduced in Alzheimer's Disease Patients and Correlates with Cognitive Performance.”, J Alzheimers Dis, vol. 77, no. 2, pp. 733-744, 2020.
S. Pedrini, Hone, E., Gupta, V. B., James, I., Teimouri, E., Bush, A. I., Rowe, C. C., Villemagne, V. L., Ames, D., Masters, C. L., Rainey-Smith, S., Verdile, G., Sohrabi, H. R., Raida, M. R., Wenk, M. R., Taddei, K., Chatterjee, P., Martins, I., Laws, S. M., and Martins, R. N., “Plasma High Density Lipoprotein Small Subclass is Reduced in Alzheimer's Disease Patients and Correlates with Cognitive Performance.”, J Alzheimers Dis, vol. 77, no. 2, pp. 733-744, 2020.
S. Pedrini, Hone, E., Gupta, V. B., James, I., Teimouri, E., Bush, A. I., Rowe, C. C., Villemagne, V. L., Ames, D., Masters, C. L., Rainey-Smith, S., Verdile, G., Sohrabi, H. R., Raida, M. R., Wenk, M. R., Taddei, K., Chatterjee, P., Martins, I., Laws, S. M., and Martins, R. N., “Plasma High Density Lipoprotein Small Subclass is Reduced in Alzheimer's Disease Patients and Correlates with Cognitive Performance.”, J Alzheimers Dis, vol. 77, no. 2, pp. 733-744, 2020.
P. Chatterjee, Doré, V., Pedrini, S., Krishnadas, N., Thota, R., Bourgeat, P., Ikonomovic, M. D., Rainey-Smith, S. R., Burnham, S. C., Fowler, C., Taddei, K., Mulligan, R., Ames, D., Masters, C. L., Fripp, J., Rowe, C. C., Martins, R. N., and Villemagne, V. L., “Plasma Glial Fibrillary Acidic Protein Is Associated with 18F-SMBT-1 PET: Two Putative Astrocyte Reactivity Biomarkers for Alzheimer's Disease.”, J Alzheimers Dis, vol. 92, no. 2, pp. 615-628, 2023.
P. Chatterjee, Doré, V., Pedrini, S., Krishnadas, N., Thota, R., Bourgeat, P., Ikonomovic, M. D., Rainey-Smith, S. R., Burnham, S. C., Fowler, C., Taddei, K., Mulligan, R., Ames, D., Masters, C. L., Fripp, J., Rowe, C. C., Martins, R. N., and Villemagne, V. L., “Plasma Glial Fibrillary Acidic Protein Is Associated with 18F-SMBT-1 PET: Two Putative Astrocyte Reactivity Biomarkers for Alzheimer's Disease.”, J Alzheimers Dis, vol. 92, no. 2, pp. 615-628, 2023.
K. Deniz, Ho, C. C. G., Malphrus, K. G., Reddy, J. S., Nguyen, T., Carnwath, T. P., Crook, J. E., Lucas, J. A., Graff-Radford, N. R., Carrasquillo, M. M., and Ertekin-Taner, N., “Plasma Biomarkers of Alzheimer's Disease in African Americans.”, J Alzheimers Dis, vol. 79, no. 1, pp. 323-334, 2021.
B. Rippon, Palta, P., Tahmi, M., Sherwood, G., Soto, L., Cespedes, S., Mesen, Y., He, H., Laing, K., Moreno, H., Teresi, J., Razlighi, Q., Brickman, A. M., Zetterberg, H., and Luchsinger, J. A., “Plasma Amyloid and in vivo Brain Amyloid in Late Middle-Aged Hispanics.”, J Alzheimers Dis, vol. 87, no. 3, pp. 1229-1238, 2022.
B. Rippon, Palta, P., Tahmi, M., Sherwood, G., Soto, L., Cespedes, S., Mesen, Y., He, H., Laing, K., Moreno, H., Teresi, J., Razlighi, Q., Brickman, A. M., Zetterberg, H., and Luchsinger, J. A., “Plasma Amyloid and in vivo Brain Amyloid in Late Middle-Aged Hispanics.”, J Alzheimers Dis, vol. 87, no. 3, pp. 1229-1238, 2022.
N. Marchesi, Amadio, M., Colombrita, C., Govoni, S., Ratti, A., and Pascale, A., “PKC Activation Counteracts ADAM10 Deficit in HuD-Silenced Neuroblastoma Cells.”, J Alzheimers Dis, vol. 54, no. 2, pp. 535-47, 2016.
W. A. Krudop, Dols, A., Kerssens, C. J., Eikelenboom, P., Prins, N. D., Möller, C., Schouws, S., Rhebergen, D., van Exel, E., van der Flier, W. M., Sikkes, S., Scheltens, P., Stek, M. L., and Pijnenburg, Y. A. L., “The Pitfall of Behavioral Variant Frontotemporal Dementia Mimics Despite Multidisciplinary Application of the FTDC Criteria.”, J Alzheimers Dis, vol. 60, no. 3, pp. 959-975, 2017.
L. Lu, Jia, H., Gao, G., Duan, C., Ren, J., Li, Y., and Yang, H., “Pink1 Regulates Tyrosine Hydroxylase Expression and Dopamine Synthesis.”, J Alzheimers Dis, vol. 63, no. 4, pp. 1361-1371, 2018.
B. Fenesi, Fang, H., Kovacevic, A., Oremus, M., Raina, P., and Heisz, J. J., “Physical Exercise Moderates the Relationship of Apolipoprotein E (APOE) Genotype and Dementia Risk: A Population-Based Study.”, J Alzheimers Dis, vol. 56, no. 1, pp. 297-303, 2017.
G. Ben-Sadoun, Sacco, G., Manera, V., Bourgeois, J., König, A., Foulon, P., Fosty, B., Bremond, F., d'Arripe-Longueville, F., and Robert, P., “Physical and Cognitive Stimulation Using an Exergame in Subjects with Normal Aging, Mild and Moderate Cognitive Impairment.”, J Alzheimers Dis, vol. 53, no. 4, pp. 1299-314, 2016.
E. Curran, Palmer, V. J., Ellis, K. A., Chong, T. W. H., Rego, T., Cox, K. L., Anstey, K. J., Westphal, A., Moorhead, R., Southam, J., Lai, R., You, E., and Lautenschlager, N. T., “Physical Activity for Cognitive Health: A Model for Intervention Design for People Experiencing Cognitive Concerns and Symptoms of Depression or Anxiety.”, J Alzheimers Dis, vol. 94, no. 2, pp. 781-799, 2023.

Pages